Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medicinova (MNOV) EPS (Basic) (2021 - 2025)

Medicinova (MNOV) has disclosed EPS (Basic) for 7 consecutive years, with -$0.07 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) changed N/A to -$0.07 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.26, a N/A change, with the full-year FY2025 number at -$0.24, down 4.35% from a year prior.
  • EPS (Basic) was -$0.07 for Q4 2025 at Medicinova, down from -$0.07 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.07 in Q4 2021 to a low of -$0.09 in Q2 2021.
  • A 5-year average of -$0.05 and a median of -$0.06 in 2023 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): plummeted 1918.35% in 2022, then surged 85.71% in 2023.
  • Medicinova's EPS (Basic) stood at $0.07 in 2021, then tumbled by 200.0% to -$0.07 in 2022, then soared by 42.86% to -$0.04 in 2023, then plummeted by 50.0% to -$0.06 in 2024, then decreased by 16.67% to -$0.07 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's EPS (Basic) are -$0.07 (Q4 2025), -$0.07 (Q3 2025), and -$0.07 (Q2 2025).